nitrites has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Hastings, TG; LaVoie, MJ | 1 |
| Choi, JY; Jang, EH; Kang, JH; Park, CS | 1 |
| Chung, H; Hwang, L; Hwang, S; Kim, HG; Kim, S; Lee, D; Lee, KT; Moon, M; Oh, MS; Park, S; Seo, JH | 1 |
| Cho, Y; Choi, DH; Choi, JH; Hwang, O; Ji, IJ; Joh, TH; Kim, EM; Kim, ST; Kim, YS; Son, HJ | 1 |
| Gupta, A; Kulkarni, SK; Kumar, A | 1 |
| Acuña-Castroviejo, D; Camacho, E; Carrión, MD; Doerrier, C; Escames, G; Espinosa, A; López, LC; Mora, F; Tapias, V | 1 |
| Agarwal, S; Bhatnagar, P; Brashket, S; Chaturvedi, RK; Gupta, KC; Kumar, P; Patel, DK; Singh, MP; Singhal, NK; Srivastava, G; Tiwari, MN; Tiwari, SK | 1 |
| Birla, H; Dilnashin, H; Keswani, C; Rai, SN; Rathore, AS; Singh, R; Singh, RK; Singh, SP; Singh, SS; Zahra, W | 1 |
| Datta, I; Ganapathy, K; Kaushal, A; Mekha, SR; Razdan, R | 1 |
9 other study(ies) available for nitrites and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alcohol Dehydrogenase; Antioxidants; Apoptosis; Catalase; Chromatography, High Pressure Liquid; Dopamine; Hydrogen-Ion Concentration; Methamphetamine; Monophenol Monooxygenase; Nerve Tissue Proteins; Neurons; Nitrates; Nitric Oxide; Nitrites; Oxidants; Oxidation-Reduction; Parkinson Disease; Protein Binding; Sulfhydryl Compounds; Superoxide Dismutase | 1999 |
Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animal Feed; Animals; Antioxidants; Astrocytes; Blotting, Western; Body Weight; Chromatography, High Pressure Liquid; Dietary Fats; Disease Susceptibility; Dopamine; Dopamine Agents; Glial Fibrillary Acidic Protein; Immunoblotting; Immunohistochemistry; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mice, Obese; MPTP Poisoning; Neurons; Neurotoxicity Syndromes; Nitrates; Nitric Oxide; Nitrites; Obesity; Oxidative Stress; Phosphorylation; Substantia Nigra; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Time Factors; Tyrosine | 2005 |
Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Animals, Newborn; Cells, Cultured; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Embryo, Mammalian; Gene Expression Regulation; Ghrelin; Gliosis; Interleukin-1beta; Male; Matrix Metalloproteinase 3; Mesencephalon; Mice; Mice, Inbred C57BL; Microglia; Motor Activity; MPTP Poisoning; Nerve Degeneration; Neurons; Neuroprotective Agents; Nitrites; Rats; Receptors, Ghrelin; Tandem Mass Spectrometry; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2009 |
Doxycycline is neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Death; Cells, Cultured; Dopamine; Dose-Response Relationship, Drug; Doxycycline; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Enzymologic; In Situ Nick-End Labeling; L-Lactate Dehydrogenase; Male; Matrix Metalloproteinase 3; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Nitrites; Pregnancy; Rats; Rats, Sprague-Dawley; Silver Staining; Statistics, Nonparametric; Substantia Nigra; Tumor Necrosis Factor-alpha | 2009 |
Licofelone attenuates MPTP-induced neuronal toxicity: behavioral, biochemical and cellular evidence.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Behavior, Animal; Caspase 3; Cyclooxygenase Inhibitors; Lipid Peroxidation; Lipoxygenase Inhibitors; Mice; Mitochondria; Motor Activity; MPTP Poisoning; Neuroprotective Agents; NF-kappa B; Nitrites; Oxidative Stress; Pyrroles | 2010 |
Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Cytosol; Disease Models, Animal; Drug Administration Schedule; Kynurenine; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mitochondria; MPTP Poisoning; NAD; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitrites; Oxidation-Reduction; Substantia Nigra | 2011 |
Mechanism of Nanotization-Mediated Improvement in the Efficacy of Caffeine Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Active Transport, Cell Nucleus; Animals; Biological Transport; Caffeine; Cell Count; Cell Nucleus; Cell Survival; Dopamine; Dopaminergic Neurons; Drug Carriers; Drug Liberation; Fluorescein-5-isothiocyanate; GAP-43 Protein; Gene Expression Regulation; Lactic Acid; Lipid Peroxidation; Male; Mice; Microglia; Nanoparticles; Neuroprotective Agents; NF-kappa B; Nitrites; Parkinsonian Disorders; Phosphoproteins; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proto-Oncogene Proteins c-akt; RNA, Messenger | 2015 |
Anti-inflammatory Activity of Ursolic Acid in MPTP-Induced Parkinsonian Mouse Model.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Antiparkinson Agents; Brain; Catalase; Fluorescent Antibody Technique; Glutathione; Inflammation; Lipid Peroxidation; Male; Malondialdehyde; Mice; Nitrites; Parkinsonian Disorders; Psychomotor Performance; Real-Time Polymerase Chain Reaction; Rotarod Performance Test; Triterpenes; Ursolic Acid | 2019 |
Influence of intranasal exposure of MPTP in multiple doses on liver functions and transition from non-motor to motor symptoms in a rat PD model.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Intranasal; Alanine Transaminase; Animals; Aspartate Aminotransferases; Catalase; Corpus Striatum; Disease Models, Animal; Dopamine; gamma-Aminobutyric Acid; Liver; Male; Motor Activity; Nitrites; Norepinephrine; Parkinson Disease; Rats, Wistar; Serotonin; Smell; Superoxide Dismutase | 2020 |